Clinical Trials · NCT01789281

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

Name: Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 4Octreotide

Phase: Phase 4
Recruitment status: Completed
Sponsor: Novartis Pharmaceuticals
Enrollment: 34
Start date: May 2013
Locations: 24 sites, 9 countries
Primary endpoint: Percentage of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)

View Octreotide compound reference